Reijnders, Jurrien G.

Publishing since 2008 (Baby)

Has published 6 publications in 3 years

Number of publications published per year by Reijnders, Jurrien G.. (Source : PubMed)

Distribution of publications types for Reijnders, Jurrien G.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL. Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients with Chronic Hepatitis B.  Gastroenterology  2010  
•  Reijnders JG, Deterding K, Petersen J, Zoulim F, Santantonio T, Buti M, van Bömmel F, Hansen BE, Wedemeyer H, Janssen HL. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.  J. Hepatol.  2010;52;4  
•  Janssen HL, Reijnders JG. Treatment with nucleos(t)ide analogues in chronic hepatitis B: where does the road map lead us?  J. Hepatol.  2009;51;1  
•  Reijnders JG, Pas SD, Schutten M, de Man RA, Janssen HL. Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.  J. Hepatol.  2009;50;4  
•  Reijnders JG, Leemans WF, Hansen BE, Pas SD, de Man RA, Schutten M, Janssen HL. On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.  J. Viral Hepat.  2009;16;2  
•  Reijnders JG, Janssen HL. How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?  Nature clinical practice. Gastroenterology & hepatology  2008;5;12  
•  Reijnders JG, Janssen HL. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?  J. Hepatol.  2008;48;3  

[ See timeline ] [ See all publications ]